These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21725313)

  • 1. Potent amyloidogenicity and pathogenicity of Aβ43.
    Saito T; Suemoto T; Brouwers N; Sleegers K; Funamoto S; Mihira N; Matsuba Y; Yamada K; Nilsson P; Takano J; Nishimura M; Iwata N; Van Broeckhoven C; Ihara Y; Saido TC
    Nat Neurosci; 2011 Jul; 14(8):1023-32. PubMed ID: 21725313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Ubiquilin-1 Alleviates Alzheimer's Disease-Caused Cognitive and Motor Deficits and Reduces Amyloid-β Accumulation in Mice.
    Adegoke OO; Qiao F; Liu Y; Longley K; Feng S; Wang H
    J Alzheimers Dis; 2017; 59(2):575-590. PubMed ID: 28598849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease.
    Peng Y; Sun J; Hon S; Nylander AN; Xia W; Feng Y; Wang X; Lemere CA
    J Neurosci; 2010 Jun; 30(24):8180-9. PubMed ID: 20554868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and deposition of Aβ43 by the virtually inactive presenilin-1 L435F mutant contradicts the presenilin loss-of-function hypothesis of Alzheimer's disease.
    Kretner B; Trambauer J; Fukumori A; Mielke J; Kuhn PH; Kremmer E; Giese A; Lichtenthaler SF; Haass C; Arzberger T; Steiner H
    EMBO Mol Med; 2016 May; 8(5):458-65. PubMed ID: 26988102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-β pathology in a mouse model of Alzheimer's disease.
    Li L; Zhang S; Zhang X; Li T; Tang Y; Liu H; Yang W; Le W
    Curr Alzheimer Res; 2013 May; 10(4):433-41. PubMed ID: 23305067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotective Effect of SLM, a Novel Carbazole-Based Fluorophore, on SH-SY5Y Cell Model and 3xTg-AD Mouse Model of Alzheimer's Disease.
    Wu X; Kosaraju J; Zhou W; Tam KY
    ACS Chem Neurosci; 2017 Mar; 8(3):676-685. PubMed ID: 28032988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear translocation uncovers the amyloid peptide Aβ42 as a regulator of gene transcription.
    Barucker C; Harmeier A; Weiske J; Fauler B; Albring KF; Prokop S; Hildebrand P; Lurz R; Heppner FL; Huber O; Multhaup G
    J Biol Chem; 2014 Jul; 289(29):20182-91. PubMed ID: 24878959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switched Aβ43 generation in familial Alzheimer's disease with presenilin 1 mutation.
    Kakuda N; Takami M; Okochi M; Kasuga K; Ihara Y; Ikeuchi T
    Transl Psychiatry; 2021 Nov; 11(1):558. PubMed ID: 34728605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abca1 deficiency affects Alzheimer's disease-like phenotype in human ApoE4 but not in ApoE3-targeted replacement mice.
    Fitz NF; Cronican AA; Saleem M; Fauq AH; Chapman R; Lefterov I; Koldamova R
    J Neurosci; 2012 Sep; 32(38):13125-36. PubMed ID: 22993429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
    Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
    Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice.
    Kimura R; Devi L; Ohno M
    J Neurochem; 2010 Apr; 113(1):248-61. PubMed ID: 20089133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autophagy impairment by caspase-1-dependent inflammation mediates memory loss in response to β-Amyloid peptide accumulation.
    Álvarez-Arellano L; Pedraza-Escalona M; Blanco-Ayala T; Camacho-Concha N; Cortés-Mendoza J; Pérez-Martínez L; Pedraza-Alva G
    J Neurosci Res; 2018 Feb; 96(2):234-246. PubMed ID: 28801921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer's disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition.
    Stumm C; Hiebel C; Hanstein R; Purrio M; Nagel H; Conrad A; Lutz B; Behl C; Clement AB
    Neurobiol Aging; 2013 Nov; 34(11):2574-84. PubMed ID: 23838176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression.
    Devi L; Tang J; Ohno M
    Curr Alzheimer Res; 2015; 12(1):13-21. PubMed ID: 25523425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.
    Dumont M; Kipiani K; Yu F; Wille E; Katz M; Calingasan NY; Gouras GK; Lin MT; Beal MF
    J Alzheimers Dis; 2011; 27(1):211-23. PubMed ID: 21799249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of Alzheimer's disease-related phenotypes by expression of heat shock protein 70 in mice.
    Hoshino T; Murao N; Namba T; Takehara M; Adachi H; Katsuno M; Sobue G; Matsushima T; Suzuki T; Mizushima T
    J Neurosci; 2011 Apr; 31(14):5225-34. PubMed ID: 21471357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aβ43 in human Alzheimer's disease: effects of active Aβ42 immunization.
    Jäkel L; Boche D; Nicoll JAR; Verbeek MM
    Acta Neuropathol Commun; 2019 Sep; 7(1):141. PubMed ID: 31477180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice as a model of pre-clinical Alzheimer's disease.
    Ferretti MT; Partridge V; Leon WC; Canneva F; Allard S; Arvanitis DN; Vercauteren F; Houle D; Ducatenzeiler A; Klein WL; Glabe CG; Szyf M; Cuello AC
    Curr Alzheimer Res; 2011 Feb; 8(1):4-23. PubMed ID: 21143159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.